The Significance and Laboratry Analysis in Acute Leukemia Patients with Disseminated Intravascular Coagulation
Qiao Zhe-hua
Abstract
Qiao Zhe-hua
Abstract
Objective: To investigate changes of disseminated intravascular coagulation (DIC) in acute leukemia(AL) and to discuss its implication. Methods: Screening tests of blood coagulation(activated partial thromboplastine time ( APTT), thrombin time(TT), prothrombin time(PT), fibrinogen(Fbg), D-Dimer, fibninogen degradation products and plasma protamine paracoagulation test were detected in 487 patients with AL. Results: There was significant difference between DIC groups and non-DIC groups withAL(PT P0.05, APTT P0.01). The patients with acute promyelocytic leukemia(APL) was abnormalsignificantly in lab detection, which is concided with clinical conditions, the lab index(except Fbg) was more abnormal in hybrid acute leukemia(HAL) and chronic myelogenous leukemia-accclarated phase(CML-AP) than other subtypes AL. D-Dimer abnormal rate was 96.06%, it indicated that D-Dimer was a special index in early diagnosis for DIC. Conclusion: According to abnormalities of DIC results, not only can reach a prompt diagnosis of DIG, but it also gave patients timely prevention and treatment, so to decrease the mortality of DIC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate changes of disseminated intravascular coagulation (DIC) in acute leukemia(AL) and to discuss its implication. Methods: Screening tests of blood coagulation(activated partial thromboplastine time ( APTT), thrombin time(TT), prothrombin time(PT), fibrinogen(Fbg), D-Dimer, fibninogen degradation products and plasma protamine paracoagulation test were detected in 487 patients with AL. Results: There was significant difference between DIC groups and non-DIC groups withAL(PT P0.05, APTT P0.01). The patients with acute promyelocytic leukemia(APL) was abnormalsignificantly in lab detection, which is concided with clinical conditions, the lab index(except Fbg) was more abnormal in hybrid acute leukemia(HAL) and chronic myelogenous leukemia-accclarated phase(CML-AP) than other subtypes AL. D-Dimer abnormal rate was 96.06%, it indicated that D-Dimer was a special index in early diagnosis for DIC. Conclusion: According to abnormalities of DIC results, not only can reach a prompt diagnosis of DIG, but it also gave patients timely prevention and treatment, so to decrease the mortality of DIC.
Key concepts: Medicine, Disseminated intravascular coagulation, Fibrinogen, Acute promyelocytic leukemia, Internal medicine, Prothrombin time, Gastroenterology, Coagulation